Company Profile

Athens Research & Technology Inc
Profile last edited on: 10/25/16      CAGE:       UEI:

Business Identifier: Manufacturer of purified human proteins, enzymes and cell culture supplements.
Year Founded
1986
First Award
1988
Latest Award
1991
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

110 Trans Tech Drive
Athens, GA 30601
   (706) 546-0207
   artbio@athensresearch.com
   www.athensresearch.com
Location: Single
Congr. District: 09
County: Clarke

Public Profile

Athens Research & Technology Inc. has been purifying human proteins and developing polyclonal antisera to those proteins since 1986. They specialize in highly pure, highly active human proteins. Athens routinely purify serine proteases, protease inhibitors, neutrophil enzymes, apolipoproteins, lipoproteins, platelet proteins, transferrins, immunoglobulins, and more. Their research reagents are actively being used by the research communities for the studies of inflammation, autoimmune disease, cancer, coronary disease, Alzheimer’s disease and more. Athens also works with the purification of human proteins from plasma, erythrocytes, neutrophils, and other tissues

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
25-49
Revenue Range
2.5M-5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
1991 1 NIH $50,000
Project Title: Use of antibodies to modified alph 1 antichymotrypsin
1990 2 NIH $350,000
Project Title: Rapid assay for human Alpha-1-proteinase inhibitor deficiency
1990 2 USDA $275,000
Project Title: A Quick Diagnostic Test To Detect A Deadly Bacteria Infecting Channel Catfish
1989 1 NIH $50,000
Project Title: Polymeric membrane applications to improve cell culture
1988 1 NIH $50,000
Project Title: Antibodies to human pancreatic trypsin & trypsinogen

Key People / Management

  Paula G Ciembor

  Cynthia A Lloyd

  Virginia B Patel

Company News

There are no news available.